Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Perrigo Company plc
  6. Summary
    PRGO   IE00BGH1M568

PERRIGO COMPANY PLC

(PRGO)
  Report
Delayed Quote. Delayed Nyse - 12/03 04:10:00 pm
35.79 USD   -0.11%
12/02PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/25Company valuations and climate strategies are poles apart
RE
11/22Perrigo to Delist From Tel Aviv Stock Exchange
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
37.48(c) 36.71(c) 35.85(c) 35.83(c) 35.79(c) Last
1 309 360 1 972 691 2 662 481 2 494 549 1 269 838 Volume
-0.79% -2.05% -2.34% -0.06% -0.11% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4 126 M - -
Net income 2021 - - -
Net Debt 2021 1 858 M - -
P/E ratio 2021 -27,7x
Yield 2021 2,79%
Sales 2022 4 485 M - -
Net income 2022 - - -
Net Debt 2022 3 867 M - -
P/E ratio 2022 -71,6x
Yield 2022 3,07%
Capitalization 4 788 M 4 788 M -
EV / Sales 2021 1,61x
EV / Sales 2022 1,93x
Nbr of Employees 11 500
Free-Float 99,3%
More Financials
Company
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract... 
Read more
Sector
Pharmaceuticals
Calendar
12/02Ex-dividend day for
More about the company
Ratings of Perrigo Company plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PERRIGO COMPANY PLC
12/02PERRIGO COMPANY PLC : Ex-dividend day for
FA
11/25Company valuations and climate strategies are poles apart
RE
11/22Perrigo to Delist From Tel Aviv Stock Exchange
MT
11/22PERRIGO CO PLC : Other Events (form 8-K)
AQ
11/22Perrigo Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE)
PR
11/15PERRIGO : Immediate Report
PU
11/12PERRIGO CO PLC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
11/11Raymond James Adjusts Price Target on Perrigo to $55 From $59, Maintains Outperform Rat..
MT
11/10Perrigo, Wendy's fall; RingCentral, Newmont rise
AQ
11/10Health Care Stocks Decline Premarket Wednesday
MT
11/10Perrigo's Q3 Adjusted Earnings Decline, Sales Rise; Updates 2021 Adjusted EPS Outlook
MT
11/10PERRIGO REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS FROM CONTINUING OPERATIONS - Form ..
PU
11/10PERRIGO : Q3 Earnings Snapshot
AQ
11/10Earnings Flash (PRGO) PERRIGO COMPANY Reports Q3 EPS $0.45, vs. Street Est of $0.65
MT
11/10Earnings Flash (PRGO) PERRIGO COMPANY Posts Q3 Revenue $1.04B, vs. Street Est of $1.052..
MT
More news
News in other languages on PERRIGO COMPANY PLC
11/22Perrigo va se retirer de la Bourse de Tel Aviv
11/10Les actions du secteur de la santé en baisse mercredi avant le marché
11/10PERRIGO : baisse du bénéfice ajusté au 3e trimestre, hausse des ventes ; mise à jour des p..
11/10Earnings Flash (PRGO) PERRIGO COMPANY affiche un chiffre d'affaires de 1,04 milliard de..
11/10L'agenda di oggi
More news
Analyst Recommendations on PERRIGO COMPANY PLC
More recommendations
Analysis
Wall Street ends lower, weighed down by Big Tech
Chart PERRIGO COMPANY PLC
Duration : Period :
Perrigo Company plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PERRIGO COMPANY PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 35,79 $
Average target price 54,75 $
Spread / Average Target 53,0%
EPS Revisions
Managers and Directors
Murray S. Kessler President, Chief Executive Officer & Director
Raymond P. Silcock CFO, Principal Accounting Officer & Executive VP
Rolf Allan Classon Chairman
Thomas M. Farrington Chief Information Officer & Executive VP
Grainne Quinn Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
PERRIGO COMPANY PLC-19.88%4 788
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
PFIZER, INC.44.09%304 610
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641